eATP and autoimmune diabetes

Atkinson, 2001, Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet, 358, 221, 10.1016/S0140-6736(01)05415-0 Naserke, 2001, Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes, J. Clin. Endocrinol. Metab., 86, 4826, 10.1210/jcem.86.10.7931 Vergani, 2013, Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7, Circulation, 127, 463, 10.1161/CIRCULATIONAHA.112.123653 Tezza, 2018, Islet-derived eATP fuels autoreactive CD8(+) T cells and facilitates the onset of type 1 diabetes, Diabetes, 67, 2038, 10.2337/db17-1227 Lind, 2014, Glycemic control and excess mortality in type 1 diabetes, N. Engl. J. Med., 371, 1972, 10.1056/NEJMoa1408214 Onaca, 2004, Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus, Nutr. Clin. Pract., 19, 154, 10.1177/0115426504019002154 Fiorina, 2008, The clinical impact of islet transplantation, Am. J. Transpl., 8, 1990, 10.1111/j.1600-6143.2008.02353.x Vantyghem, 2009, Primary graft function, metabolic control, and graft survival after islet transplantation, Diabetes Care, 32, 1473, 10.2337/dc08-1685 Loretelli, 2020, Cell therapy for type 1 diabetes, Expert Opin. Biol. Ther., 20, 887, 10.1080/14712598.2020.1748596 Niederhaus, 2013, Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes, Am. J. Transpl., 13, 2945, 10.1111/ajt.12443 Ryan, 2005, Five-year follow-up after clinical islet transplantation, Diabetes, 54, 2060, 10.2337/diabetes.54.7.2060 Di Virgilio, 2017, Extracellular purines, purinergic receptors and tumor growth, Oncogene, 36, 293, 10.1038/onc.2016.206 Ralevic, 1998, Receptors for purines and pyrimidines, Pharmacol. Rev., 50, 413 Khakh, 2006, P2X receptors as cell-surface ATP sensors in health and disease, Nature, 442, 527, 10.1038/nature04886 Wilhelm, 2010, Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R, Nat. Med., 16, 1434, 10.1038/nm.2242 Junger, 2011, Immune cell regulation by autocrine purinergic signalling, Nat. Rev. Immunol., 11, 201, 10.1038/nri2938 Vergani, 2014, The purinergic system in allotransplantation, Am. J. Transpl., 14, 507, 10.1111/ajt.12567 Vergani, 2013, Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection, Diabetes, 62, 1665, 10.2337/db12-0242 Burnstock, 2018, The therapeutic potential of purinergic signalling, Biochem. Pharmacol., 151, 157, 10.1016/j.bcp.2017.07.016 Zimmermann, 2016, Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release, Purinergic Signal., 12, 25, 10.1007/s11302-015-9483-2 Surprenant, 2009, Signaling at purinergic P2X receptors, Annu. Rev. Physiol., 71, 333, 10.1146/annurev.physiol.70.113006.100630 Zimmermann, 2012, Cellular function and molecular structure of ecto-nucleotidases, Purinergic Signal., 8, 437, 10.1007/s11302-012-9309-4 Langer, 2008, Distribution of ectonucleotidases in the rodent brain revisited, Cell Tissue Res., 334, 199, 10.1007/s00441-008-0681-x Young, 2013, The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29, Mol. Asp. Med., 34, 529, 10.1016/j.mam.2012.05.007 Ayna, 2012, ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages, PLOS One, 7, 10.1371/journal.pone.0040069 Cekic, 2016, Purinergic regulation of the immune system, Nat. Rev. Immunol., 16, 177, 10.1038/nri.2016.4 Schenk, 2011, ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors, Sci. Signal., 4, 10.1126/scisignal.2001270 Novak, 2008, Purinergic receptors in the endocrine and exocrine pancreas, Purinergic Signal., 4, 237, 10.1007/s11302-007-9087-6 Burnstock, 2012, Purinergic signalling in the pancreas in health and disease, J. Endocrinol., 213, 123, 10.1530/JOE-11-0434 Burnstock, 2013, Purinergic signalling and diabetes, Purinergic Signal., 9, 307, 10.1007/s11302-013-9359-2 Fotino, 2018, Emerging roles of purinergic signaling in diabetes, Med. Chem., 14, 428, 10.2174/1573406414666180226165204 Jacques-Silva, 2010, ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell, Proc. Natl. Acad. Sci. USA, 107, 6465, 10.1073/pnas.0908935107 Richards-Williams, 2008, Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion, Purinergic Signal., 4, 393, 10.1007/s11302-008-9126-y Santini, 2009, Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtype, Endocrinology, 150, 2596, 10.1210/en.2008-1486 Ohtani, 2008, Evidence for the possible involvement of the P2Y(6) receptor in Ca (2+) mobilization and insulin secretion in mouse pancreatic islets, Purinergic Signal., 4, 365, 10.1007/s11302-008-9122-2 Coutinho-Silva, 2001, Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing, Cell Tissue Res., 306, 373, 10.1007/s004410100458 Coutinho-Silva, 2003, P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats, Mol. Cell Endocrinol., 204, 141, 10.1016/S0303-7207(03)00003-0 Coutinho-Silva, 2007, Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes, Autoimmunity, 40, 108, 10.1080/08916930601118841 Vieira, 2016, P2X7 receptor knockout prevents streptozotocin-induced type 1 diabetes in mice, Mol. Cell Endocrinol., 419, 148, 10.1016/j.mce.2015.10.008 Akesson, 2015, Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease, Clin. Exp. Immunol., 180, 70, 10.1111/cei.12559 Jin, 2019, Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients, J. Diabetes, 11, 440, 10.1111/1753-0407.12870 Castillo-Leon, 2018, ATP and T-cell-mediated rejection, Curr. Opin. Organ Transpl., 23, 34, 10.1097/MOT.0000000000000484 Elliott, 2009, Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance, Nature, 461, 282, 10.1038/nature08296 Schenk, 2008, Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels, Sci. Signal., 1, ra6, 10.1126/scisignal.1160583 Piccini, 2008, ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way, Proc. Natl. Acad. Sci. USA, 105, 8067, 10.1073/pnas.0709684105 Di Virgilio, 2017, The P2X7 receptor in infection and inflammation, Immunity, 47, 15, 10.1016/j.immuni.2017.06.020 Atarashi, 2008, ATP drives lamina propria T(H)17 cell differentiation, Nature, 455, 808, 10.1038/nature07240 Deng, 2019, Inflammasome activation and Th17 responses, Mol. Immunol., 107, 142, 10.1016/j.molimm.2018.12.024 Fotino, 2015, P2X receptors and diabetes, Curr. Med. Chem., 22, 891, 10.2174/0929867321666141012173520 Lang, 2010, Oxidized ATP inhibits T-cell-mediated autoimmunity, Eur. J. Immunol., 40, 2401, 10.1002/eji.200939838 Liu, 2014, Inhibition of the purinergic pathway prolongs mouse lung allograft survival, Am. J. Respir. Cell Mol. Biol., 51, 300, 10.1165/rcmb.2013-0362OC Woehrle, 2010, Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse, Blood, 116, 3475, 10.1182/blood-2010-04-277707 Durr, 2012, Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissue, Immunology, 137, 80, 10.1111/j.1365-2567.2012.03610.x Klambt, 2015, A novel function for P2Y2 in myeloid recipient-derived cells during graft-versus-host disease, J. Immunol., 195, 5795, 10.4049/jimmunol.1501357 Kinsey, 2012, Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection, J. Am. Soc. Nephrol., 23, 1528, 10.1681/ASN.2012010070 Ohta, 2012, The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway, Front. Immunol., 3, 190, 10.3389/fimmu.2012.00190 Chhabra, 2010, Adenosine A(2A) agonist administration improves islet transplant outcome: evidence for the role of innate immunity in islet graft rejection, Cell Transpl., 19, 597, 10.3727/096368910X491806 Chia, 2013, The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice, Diabetes, 62, 2026, 10.2337/db12-0625 Ghaemi Oskouie, 2011, High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice, J. Immunol., 186, 6798, 10.4049/jimmunol.1004222 Usuelli, 2022, Novel soluble mediators of innate immune system activation in solid allograft rejection, Transplantation, 106, 500, 10.1097/TP.0000000000003834 Lum, 1980, Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside, J. Surg. Res., 28, 44, 10.1016/0022-4804(80)90081-5 Mishra, 2016, A critical role for P2X7 receptor-induced VCAM-1 shedding and neutrophil infiltration during acute lung injury, J. Immunol., 197, 2828, 10.4049/jimmunol.1501041 Leyva-Grado, 2017, Contribution of the purinergic receptor P2X7 to development of lung immunopathology during influenza virus infection, mBio, 8, 10.1128/mBio.00229-17 Guerra Martinez, 2019, P2X7 receptor in cardiovascular disease: the heart side, Clin. Exp. Pharmacol. Physiol., 46, 513, 10.1111/1440-1681.13079 D'Addio, 2018, P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes, J. Clin. Investig., 128, 3490, 10.1172/JCI94524 Biswas, 2019, Loss of function mutation in the P2X7, a ligand-gated ion channel gene associated with hypertrophic cardiomyopathy, Purinergic Signal., 15, 205, 10.1007/s11302-019-09660-7